Aspirin non-responder status in patients with recurrent cerebral ischemic attacks
about
sameAs
Antiplatelet resistance in strokeThe antithrombotic profile of aspirin. Aspirin resistance, or simply failure?Aspirin resistance: an evaluation of current evidence and measurement methodsAssessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIAA critical appraisal of the phenomenon of aspirin resistanceAntiplatelet therapy in ischemic strokeAspirin resistanceAspirin resistance in secondary stroke preventionAspirin resistance and its implications in clinical practiceBiological effects of aspirin and clopidogrel in a randomized cross-over study in 96 healthy volunteersThromboelastography: potential bedside tool to assess the effects of antiplatelet therapy?Plasma levels of the growth arrest-specific gene 6 product (Gas6) and antiplatelet drug responsiveness in healthy subjectsAntithrombotic properties of aspirin and resistance to aspirin: beyond strictly antiplatelet actionsRecent advance in antiplatelet therapy: the mechanisms, evidence and approach to the problemsClinical implications of aspirin resistancePolypharmacology: drug discovery for the future.Aspirin resistance: Fact or fiction? A point of view.The evaluation method for antiplatelet effect of acetylsalicylic acid.Aldose reductase, oxidative stress, and diabetic mellitus.Platelet function testing in cardiovascular diseases.Antiplatelet drug resistance: not ready for prime time.Pharmacogenomics of platelet responsiveness to aspirin.Use of the PFA-100 closure time to predict cardiovascular events in aspirin-treated cardiovascular patients: a systematic review and meta-analysis.Platelet hyperactivity in type 2 diabetes: role of antiplatelet agents.Aspirin resistance: disparities and clinical implications.Stroke and atherothrombosis: an update on the role of antiplatelet therapy.Leukocyte count is associated with increased platelet reactivity and diminished response to aspirin in healthy individuals with a family history of coronary artery disease.Prospective, observational study of antiplatelet and coagulation biomarkers as predictors of thromboembolic events after implantation of ventricular assist devices.A clinician's perspective of emerging P2Y(12)-directed pharmacotherapies, ex vivo measurement tools, and clinical outcomes.Resistance to aspirin and clopidogrel therapy.Functional testing methods for the antiplatelet effects of aspirin.Antiplatelet therapy: aspirin resistance and all that jazz!Overcoming aspirin treatment failure in diabetes.High on-treatment platelet reactivity in peripheral endovascular procedures.Aspirin resistance: a clinical review focused on the most common cause, noncompliance.Antiplatelet drug resistance is associated with early neurological deterioration in acute minor ischemic stroke in the Chinese population.Platelet function testing in transient ischaemic attack and ischaemic stroke: A comprehensive systematic review of the literature.Antiplatelet Resistance-Does it Exist and How to Measure it?Platelet transcriptome and cardiovascular disease.Aspirin resistance.
P2860
Q22305927-5A0BD230-706B-49F9-8278-1926F8E1BC40Q24794673-80FBFAAB-BEDA-416E-953B-95047298A070Q28183220-7536D474-9240-4B18-B144-E1BBACE7024BQ28183545-A75CB05A-FD59-4998-89A0-CA32215BFDCEQ28183919-FCBE01D5-F719-4BB9-824E-DCE724653250Q28184366-6F684402-06D9-42C9-ADF4-29AE4114D8D7Q28187611-F12C8A4D-81B2-42E0-BA21-5800B868C4C6Q28194036-66FB2415-C9B8-4C24-B345-FCB6A5CBFE0EQ28194069-A276D65A-E0F9-4184-AFBE-67BC78AFD6DEQ28196714-01B3D49C-7DD8-438A-98AE-F6525CD5AE36Q28200486-E6BE1C72-E1A0-4F20-8EF3-76E0D2843F61Q28200541-29E086FE-9305-4842-85F6-3D1184E6E5ACQ28211940-203306F3-B123-426B-9E67-7CB95EECFFB8Q28218351-FEE96AF2-FBBB-4D1C-90C1-853E5808D744Q28221576-3E0E9BFB-8799-4862-9EF5-179DCA7FA3EEQ34319906-066DFD0E-87C1-4651-9442-A712AA5936D4Q34389630-C97C953F-08CE-4E79-8C09-5E6D9FB193FDQ35074234-A4520B97-5326-41E4-AC2A-4636FB086C50Q35947855-03D9D651-CCB5-49C9-B232-B6B452455911Q36270009-8DE55BA5-0FF2-4FE7-8425-1EE512A18C1EQ36289432-FBE62479-DAC0-4DDD-8F89-62E30C16277DQ36989841-F105C58D-913D-411B-B2B2-9837332B906FQ37056745-3F8C4833-0A85-445F-A44B-06875D4C2F8AQ37184596-8A0C0237-C5ED-4C76-9316-47C27E7EEAFCQ37227512-D9941638-2092-408F-99E2-2CD48DBDE357Q37244407-7D192EBF-B361-4946-BBD5-5B3CFAF0F224Q37389964-5F6B1FE2-0F60-4720-8131-EE56AEBE9170Q37479004-BD93BF3C-D7CC-40B6-81DE-6FF1874036F3Q37550156-B0D43CEE-28B6-4C38-B382-50DCAE8B950FQ37807524-215606A8-6DE5-4AC8-A660-E5FAAD8A59EDQ37841562-5654601A-42FD-43E3-BEAC-C425CFC0572BQ38023196-FCAE9963-C3DE-4CAA-ACCD-897BD427F3CEQ38055245-6953C977-C5EC-4882-90C7-B4FE420F6577Q38125134-7068B130-2016-48EB-989F-9BDD35309A8BQ38132148-0C8BDDFD-DDC1-4FF5-A756-C8D0E95C97F4Q38391708-6A9E666B-6DD3-4148-AE11-E7E28FB6B876Q38515562-1EB0B44D-2747-4169-8AE6-238C9B361C45Q40014803-EE3AFCBA-BB44-4196-B165-CFD61196EEA0Q40199232-464E29A4-4BCE-4031-8FBE-A9E1EE8095C7Q42641720-0B95C348-BB7C-4032-B312-191A4C080CFF
P2860
Aspirin non-responder status in patients with recurrent cerebral ischemic attacks
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Aspirin non-responder status in patients with recurrent cerebral ischemic attacks
@ast
Aspirin non-responder status in patients with recurrent cerebral ischemic attacks
@en
Aspirin non-responder status in patients with recurrent cerebral ischemic attacks
@nl
type
label
Aspirin non-responder status in patients with recurrent cerebral ischemic attacks
@ast
Aspirin non-responder status in patients with recurrent cerebral ischemic attacks
@en
Aspirin non-responder status in patients with recurrent cerebral ischemic attacks
@nl
prefLabel
Aspirin non-responder status in patients with recurrent cerebral ischemic attacks
@ast
Aspirin non-responder status in patients with recurrent cerebral ischemic attacks
@en
Aspirin non-responder status in patients with recurrent cerebral ischemic attacks
@nl
P2093
P1433
P1476
Aspirin non-responder status in patients with recurrent cerebral ischemic attacks
@en
P2093
P2888
P356
10.1007/S00415-003-0954-Y
P407
P577
2003-01-01T00:00:00Z
P6179
1027740242